PRUEBA RÁPIDA PARA LA DETECCIÓN DE MÚLTIPLES DROGAS Y METABOLITOS DE DROGAS
Mexico·Clase I·III. Agentes de diagnóstico·ABBOTT
LABORATORIES DE
MÉXICO, S.A. DE C.V.·Registered December 05, 2022- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- SURESTEP™ URINE TEST DRUG SCREEN E-Z SPLIT KEY
- Trade Name (English)
- SURESTEP™ URINE TEST DRUG SCREEN E-Z SPLIT KEY
- Analysis ID
- 1491R2022 SSA
- Registration Date
- December 05, 2022
- Name (Spanish)
- ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.
- Name (English)
- ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.
Access comprehensive regulatory information for PRUEBA RÁPIDA PARA LA DETECCIÓN DE MÚLTIPLES DROGAS Y METABOLITOS DE DROGAS (PRUEBA RÁPIDA PARA LA DETECCIÓN DE MÚLTIPLES DROGAS Y METABOLITOS DE DROGAS) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1491R2022 SSA and manufactured by ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.. The device was registered on December 05, 2022.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.